Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 May 26;12(5):e8301.
doi: 10.7759/cureus.8301.

Chemotherapy in a Breast Cancer Patient Heterozygous Carrier of Ornithine Transcarbamylase Deficiency

Magda Palka-Kotlowska  1 , Luis Cabezón-Gutiérrez  2 , Sara Custodio-Cabello  2 , PIlar Quijada-Fraile  3 , Silvia Chumillas-Calzada  3
Affiliations
Case Reports

Chemotherapy in a Breast Cancer Patient Heterozygous Carrier of Ornithine Transcarbamylase Deficiency

Magda Palka-Kotlowska et al. Cureus. .

Abstract

Urea cycle disorders (UCDs) are an unusual genetic condition that may lead to hyperammonemia in catabolic situations such as surgery, infections or chemotherapy administration. Without specific treatment, it causes life-threatening encephalopathy. We present the case of a young woman, heterozygous carrier of ornithine transcarbamylase deficiency (OTCD) with breast cancer, who was treated with surgery, chemotherapy, radiotherapy and hormone therapy while following a protocol to minimize the risk of metabolic decompensation due to her condition.

Keywords: breast cancer; chemotherapy; ornithine transcarbamylase deficiency; urea cycle deficiency.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

References

    1. Mew NA, Simpson KL, Gropman AL, Lanpher BC, Chapman KA, Summar ML. Seattle: University of Washington; [Feb;2020 ]. 2003. Urea Cycle Disorders Overview. - PubMed
    1. A longitudinal study of urea cycle disorders. Batshaw ML, Tuchman M, Summar M, Seminara J. Mol Genet Metab. 2014;113:127–130. - PMC - PubMed
    1. World Health Organization. International Agency for Research in Cancer. Latest global cancer data, 12th Ed. [Nov;2019 ];https://www.who.int/cancer/PRGlobocanFinal.pdf 2018
    1. Population-based validation of the prognostic model ADJUVANT! for early breast cancer. Olivotto IA, Bajdik CD, Ravdin PM, et al. J Clin Oncol. 2005;23:2716–2725. - PubMed
    1. Suggested guidelines for the diagnosis and management of urea cycle disorders: first revision. Häberle J, Burlina A, Chakrapani A, et al. J Inherit Metab Dis. 2019;42:1192–1230. - PubMed

Publication types

LinkOut - more resources